Under way, not recruiting
PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs
NCT06051942 · PROCEPT BioRobotics · Updated 28 Jan 2026
- What is being tested
- Robotic Waterjet Treatment
- For
- Benign Prostatic Hyperplasia; Localized Prostate Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages Up to 80 years. About 125 people. The full rules are on the registry page.
- Where
- United States, Hong Kong, Lebanon, New Zealand (6 sites)
- When
- Starts or started 22 Nov 2022, ends March 2027. Registered 25 Sept 2023.
- Results
- None posted yet.
In the researchers' words
The goal of this clinical trial is to assess the performance and safety of the AQUABEAM Robotic System for the resection and removal of prostate tissue in patients experiencing lower urinary tract symptoms (LUTS) and are diagnosed with localized prostate cancer. Participants will go through baseline and follow up assessments up to 12 months.
Sites
- San Diego Clinical TrialsLa Mesa, California, United States
- Endeavour Health (NorthShore University HealthSystem)Glenview, Illinois, United States
- Potomac Urology CenterAlexandria, Virginia, United States
- The Chinese University of Hong KongHong Kong, Hong Kong
- American University of BeirutBeirut, Lebanon
- Tauranga Urology Research LtdTauranga, New Zealand